Kaitlin Sandor, M.D.
Research Lead
Kaitlin Sandor, M.D. is a Research Lead at Patient Square Capital. Prior to joining Patient Square, Dr. Sandor was on the corporate development and strategy team at insitro, a company leveraging machine learning and high-throughput biology for drug discovery and development. Earlier in her career, she was a Vice President on the biopharma equity research team at Guggenheim Partners, covering small-cap biotech to large pharma with a focus on immuno-oncology companies. Dr. Sandor also gained experience on the M&A team at BridgeBio and at Clarion Healthcare, a boutique life sciences consulting firm.
Dr. Sandor earned an M.D. from Emory University, graduating magna cum laude, and a B.A., cum laude, in Human Developmental and Regenerative Biology from Harvard University.
